Aggressive-variant prostate cancer features and therapeutic outcomes in patients with de-novo metastatic hormone-sensitive prostate cancer. This is an ASCO Meeting Abstract from the 2026 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results